Credit Suisse’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-184,925
| Closed | -$403K | – | 4719 |
|
|
2021
Q3 | $403K | Sell |
184,925
-18,218
| -9% | -$49.8K | ﹤0.01% | 3946 |
|
|
2021
Q2 | $761K | Sell |
203,143
-29,046
| -13% | -$101K | ﹤0.01% | 3577 |
|
|
2021
Q1 | $757K | Sell |
232,189
-128,990
| -36% | -$462K | ﹤0.01% | 3498 |
|
|
2020
Q4 | $1.23M | Buy |
361,179
+83,677
| +30% | +$344K | ﹤0.01% | 3182 |
|
|
2020
Q3 | $1.13M | Buy |
277,502
+28,863
| +12% | +$110K | ﹤0.01% | 2842 |
|
|
2020
Q2 | $840K | Buy |
248,639
+175,164
| +238% | +$510K | ﹤0.01% | 3001 |
|
|
2020
Q1 | $171K | Sell |
73,475
-19,395
| -21% | -$53.1K | ﹤0.01% | 3699 |
|
|
2019
Q4 | $338K | Buy |
92,870
+1,193
| +1% | +$9.64K | ﹤0.01% | 3769 |
|
|
2019
Q3 | $760K | Buy |
91,677
+13,898
| +18% | +$112K | ﹤0.01% | 3200 |
|
|
2019
Q2 | $670K | Sell |
77,779
-13,348
| -15% | -$119K | ﹤0.01% | 3220 |
|
|
2019
Q1 | $973K | Buy |
91,127
+9,921
| +12% | +$106K | ﹤0.01% | 2914 |
|
|
2018
Q4 | $711K | Buy |
81,206
+7,133
| +10% | +$90.9K | ﹤0.01% | 3056 |
|
|
2018
Q3 | $1.24M | Sell |
74,073
-29,186
| -28% | -$632K | ﹤0.01% | 2705 |
|
|
2018
Q2 | $2.16M | Sell |
103,259
-22,377
| -18% | -$415K | ﹤0.01% | 2382 |
|
|
2018
Q1 | $2.02M | Buy |
125,636
+14,527
| +13% | +$288K | ﹤0.01% | 2416 |
|
|
2017
Q4 | $2.1M | Sell |
111,109
-3,882
| -3% | -$70.3K | ﹤0.01% | 2395 |
|
|
2017
Q3 | $1.62M | Buy |
114,991
+20,798
| +22% | +$188K | ﹤0.01% | 2731 |
|
|
2017
Q2 | $702K | Sell |
94,193
-27,772
| -23% | -$181K | ﹤0.01% | 2914 |
|
|
2017
Q1 | $793K | Buy |
121,965
+18,018
| +17% | +$101K | ﹤0.01% | 3029 |
|
|
2016
Q4 | $461K | Buy |
103,947
+12,036
| +13% | +$50.5K | ﹤0.01% | 3494 |
|
|
2016
Q3 | $429K | Sell |
91,911
-116,619
| -56% | -$691K | ﹤0.01% | 3498 |
|
|
2016
Q2 | $1.37M | Buy |
208,530
+113,135
| +119% | +$799K | ﹤0.01% | 2649 |
|
|
2016
Q1 | $607K | Buy |
95,395
+22,493
| +31% | +$115K | ﹤0.01% | 3112 |
|
|
2015
Q4 | $440K | Sell |
72,902
-26,362
| -27% | -$151K | ﹤0.01% | 3475 |
|
|
2015
Q3 | $594K | Sell |
99,264
-86,312
| -47% | -$599K | ﹤0.01% | 3277 |
|
|
2015
Q2 | $1.27M | Buy |
185,576
+112,821
| +155% | +$716K | ﹤0.01% | 2954 |
|
|
2015
Q1 | $442K | Sell |
72,755
-105,424
| -59% | -$701K | ﹤0.01% | 3628 |
|
|
2014
Q4 | $1.24M | Buy |
178,179
+96,279
| +118% | +$708K | ﹤0.01% | 2956 |
|
|
2014
Q3 | $666K | Buy |
81,900
+13,960
| +21% | +$109K | ﹤0.01% | 3405 |
|
|
2014
Q2 | $551K | Sell |
67,940
-41,002
| -38% | -$311K | ﹤0.01% | 3759 |
|
|
2014
Q1 | $854K | Sell |
108,942
-37,277
| -25% | -$315K | ﹤0.01% | 3257 |
|
|
2013
Q4 | $1.29M | Buy |
146,219
+34,527
| +31% | +$308K | ﹤0.01% | 3058 |
|
|
2013
Q3 | $936K | Sell |
111,692
-89,604
| -45% | -$725K | ﹤0.01% | 3019 |
|
|
2013
Q2 | $1.5M | Buy |
+201,296
| New | +$1.54M | ﹤0.01% | 2477 |
|
Other funds holding SPPI
AC
Credit Suisse's SPPI Position: Q4 2021 in Review
Credit Suisse sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2021, closing a stake of 184,925 shares — an estimated $403K sold.
Credit Suisse first reported a position in SPPI in Q2 2013 and held it in 34 quarters. The position peaked at $2.16M in Q2 2018. 142 funds tracked by Wall St. Rank hold SPPI as of Q4 2021.
- Credit Suisse reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
- Credit Suisse sold 184,925 Spectrum Pharmaceuticals Inc shares in Q4 2021, an estimated $403K.
- Credit Suisse first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 34 quarters.
- Credit Suisse's Spectrum Pharmaceuticals Inc position peaked at $2.16M in Q2 2018.
- 142 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2021.
Based on Credit Suisse's 13F filing for Q4 2021, filed 14 Feb 2022.